These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 2404458

  • 41. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y, Nakagawa K, Fujiwara Y, Sasaki Y, Minato K, Bungo M, Niimi S, Horichi N, Fukuda M, Saijo N.
    Cancer Res; 1989 Aug 01; 49(15):4098-102. PubMed ID: 2472873
    [Abstract] [Full Text] [Related]

  • 42. A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells.
    Micetich KC, Barnes D, Erickson LC.
    Cancer Res; 1985 Sep 01; 45(9):4043-7. PubMed ID: 3896476
    [Abstract] [Full Text] [Related]

  • 43. [Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo].
    Akamatsu K, Endo K, Tsunenari T, Matsumoto T, Kaiho S, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Gan To Kagaku Ryoho; 1992 Feb 01; 19(2):229-35. PubMed ID: 1736835
    [Abstract] [Full Text] [Related]

  • 44. DNA synthesis, protein synthesis and platinum content following drug administration in cis-diamminedichloroplatinum(II) -sensitive and -resistant L1210 cells transferred from in vitro to in vivo conditions.
    Hanusovská E, Ujházy V.
    Neoplasma; 1987 Feb 01; 34(6):721-6. PubMed ID: 3431611
    [Abstract] [Full Text] [Related]

  • 45. Antitumor activity and cellular accumulation of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)platinum( II) monohydrate, in cisplatin-sensitive and -resistant murine P388 leukemia cells.
    Kamisango K, Matsumoto T, Akamatsu K, Morikawa K, Tashiro T, Koizumi K.
    Jpn J Cancer Res; 1992 Mar 01; 83(3):304-11. PubMed ID: 1582895
    [Abstract] [Full Text] [Related]

  • 46. In vitro cytotoxicity, pharmacokinetics and ex vivo pharmacodynamics of a new platinum compound, cis-malonato [(4R,5R-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclopentane] platinum (II).
    Kim DK, Kim HT, Cho YB, Kim TS, Kim KH, Hong WS.
    Anticancer Res; 1996 Mar 01; 16(1):251-6. PubMed ID: 8615617
    [Abstract] [Full Text] [Related]

  • 47. [Cross-resistance of HO-221 and various antitumor agents in sublines of mouse leukemia].
    Nakajima T, Masuda H, Okamoto T, Watanabe M, Yokoyama K, Yamada N, Fujimoto S, Tsukagoshi S, Taguchi T.
    Gan To Kagaku Ryoho; 1991 Feb 01; 18(2):201-9. PubMed ID: 1899547
    [Abstract] [Full Text] [Related]

  • 48. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL, Roberts BJ, Howard CT, Leopold WR.
    Cancer Res; 1994 Aug 15; 54(16):4412-8. PubMed ID: 8044790
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Antitumor activity of a new platinum compound (glycolate-o,o') diammineplatinum (II) (254-S), against non-small cell lung carcinoma grown in a human tumor clonogenic assay system.
    Kanzawa F, Matsushima Y, Nakano H, Nakagawa K, Takahashi H, Sasaki Y, Saijo N.
    Anticancer Res; 1988 Aug 15; 8(3):323-7. PubMed ID: 2839098
    [Abstract] [Full Text] [Related]

  • 51. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
    Tozawa K, Oshima T, Kobayashi T, Yamamoto N, Hayashi C, Matsumoto T, Miwa H.
    Anticancer Res; 2008 Aug 15; 28(4B):2087-92. PubMed ID: 18751380
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Initiatives with platinum- and quinazoline-based antitumor molecules--Fourteenth Bruce F. Cain Memorial Award Lecture.
    Harrap KR.
    Cancer Res; 1995 Jul 01; 55(13):2761-8. PubMed ID: 7796401
    [Abstract] [Full Text] [Related]

  • 54. cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement.
    Ara G, Kusumoto T, Korbut TT, Cullere-Luengo F, Teicher BA.
    Cancer Res; 1994 Mar 15; 54(6):1497-502. PubMed ID: 8137254
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [Development of carboplatin].
    Tsukagoshi S.
    Gan To Kagaku Ryoho; 1990 Sep 15; 17(9):1949-58. PubMed ID: 2203318
    [Abstract] [Full Text] [Related]

  • 57. Toxicity and antitumor activity of cis-bis-carboxylato(trans-R,R-1,2-diaminocyclohexane) platinum(II) complexes entrapped in liposomes.
    Khokhar AR, al-Baker S, Krakoff IH, Perez-Soler R.
    Cancer Chemother Pharmacol; 1989 Sep 15; 23(4):219-24. PubMed ID: 2647311
    [Abstract] [Full Text] [Related]

  • 58. In vivo and in vitro effectivity of some platinum complexes.
    Balázová E, Hrubisko M, Ujházy V.
    Neoplasma; 1984 Sep 15; 31(6):641-7. PubMed ID: 6395026
    [Abstract] [Full Text] [Related]

  • 59. Lack of cross-resistance between certain platinum coordination compounds in mouse leukemia.
    Burchenal JH, Kalaher K, O'Toole T, Chisholm J.
    Cancer Res; 1977 Sep 15; 37(9):3455-7. PubMed ID: 884687
    [Abstract] [Full Text] [Related]

  • 60. [Flow cytometric analysis of the effect of DWA2114R on the cell cycle traverse of RPMI 8402 cells--comparison with CDDP].
    Takamoto S, Souma R.
    Gan To Kagaku Ryoho; 1992 Apr 15; 19(4):469-76. PubMed ID: 1558396
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.